Johnson Controls International PLC tiene un precio objetivo de consenso de $107 basado en las calificaciones de 21 analistas. El máximo es $145, emitido por Argus Research el noviembre 7, 2025. El mínimo es $55, emitido por Vertical Research el diciembre 13, 2023. Las 3 calificaciones de analistas más recientes fueron publicadas por Goldman Sachs, Argus Research y RBC Capital el noviembre 7, 2025, noviembre 7, 2025 y noviembre 6, 2025, respectivamente. Con un precio objetivo promedio de $140.67 entre Goldman Sachs, Argus Research y RBC Capital, hay una 18.49% upside implícita para Johnson Controls International PLC según estas calificaciones más recientes de analistas.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/07/2025 | 19.61% | Goldman Sachs | $124 → $142 | Maintains | Buy | |||
11/07/2025 | 22.14% | Argus Research | → $145 | Reiterates | Buy → Buy | |||
11/06/2025 | 13.71% | RBC Capital | $116 → $135 | Maintains | Sector Perform | |||
11/06/2025 | 13.71% | Wells Fargo | $130 → $135 | Maintains | Overweight | |||
11/06/2025 | 0.24% | Barclays | $101 → $119 | Maintains | Equal-Weight | |||
11/06/2025 | 1.08% | Mizuho | $105 → $120 | Maintains | Neutral | |||
10/15/2025 | 5.29% | JP Morgan | $105 → $125 | Maintains | Overweight | |||
10/09/2025 | 0.24% | Citigroup | $112 → $119 | Maintains | Neutral | |||
08/21/2025 | 5.29% | Morgan Stanley | $115 → $125 | Maintains | Overweight | |||
07/30/2025 | -5.66% | Citigroup | $110 → $112 | Maintains | Neutral | |||
07/30/2025 | -3.98% | RBC Capital | $112 → $114 | Maintains | Sector Perform | |||
07/30/2025 | -14.93% | Barclays | $100 → $101 | Maintains | Equal-Weight | |||
07/24/2025 | 1.08% | Jefferies | → $120 | Downgrade | Buy → Hold | |||
07/17/2025 | -7.35% | Baird | $90 → $110 | Maintains | Neutral | |||
07/14/2025 | -7.35% | Citigroup | $94 → $110 | Maintains | Neutral | |||
07/09/2025 | -15.77% | Barclays | $90 → $100 | Maintains | Equal-Weight | |||
07/08/2025 | -2.29% | Goldman Sachs | $103 → $116 | Maintains | Buy | |||
06/20/2025 | — | Oppenheimer | — | Downgrade | Outperform → Perform | |||
06/04/2025 | 9.5% | Wells Fargo | $100 → $130 | Maintains | Overweight | |||
05/22/2025 | -2.29% | UBS | $103 → $116 | Maintains | Buy | |||
05/16/2025 | -17.45% | JP Morgan | $81 → $98 | Maintains | Overweight | |||
05/14/2025 | -24.19% | Barclays | $85 → $90 | Maintains | Equal-Weight | |||
05/12/2025 | -5.66% | Deutsche Bank | $101 → $112 | Upgrade | Hold → Buy | |||
05/09/2025 | -3.13% | Morgan Stanley | $105 → $115 | Maintains | Overweight | |||
05/08/2025 | -17.45% | RBC Capital | $82 → $98 | Maintains | Sector Perform | |||
05/08/2025 | -19.14% | Oppenheimer | $90 → $96 | Maintains | Outperform | |||
05/08/2025 | -15.77% | Wells Fargo | $82 → $100 | Maintains | Overweight | |||
05/08/2025 | -24.19% | Baird | $84 → $90 | Maintains | Neutral | |||
04/14/2025 | -28.4% | Citigroup | $95 → $85 | Maintains | Neutral | |||
04/08/2025 | -31.77% | JP Morgan | $100 → $81 | Maintains | Overweight | |||
03/10/2025 | -28.4% | Barclays | $88 → $85 | Maintains | Equal-Weight | |||
02/10/2025 | -13.24% | UBS | $90 → $103 | Upgrade | Neutral → Buy | |||
02/06/2025 | -15.77% | JP Morgan | $87 → $100 | Maintains | Overweight | |||
02/06/2025 | -21.66% | RBC Capital | $86 → $93 | Maintains | Sector Perform | |||
02/06/2025 | -17.45% | Wells Fargo | $92 → $98 | Maintains | Overweight | |||
02/06/2025 | -11.56% | Morgan Stanley | $95 → $105 | Maintains | Overweight | |||
01/28/2025 | -19.98% | Melius Research | → $95 | Downgrade | Buy → Hold | |||
01/15/2025 | -26.72% | JP Morgan | $88 → $87 | Maintains | Overweight | |||
01/13/2025 | -29.25% | Citigroup | $85 → $84 | Maintains | Neutral | |||
01/07/2025 | -22.51% | Wells Fargo | $95 → $92 | Maintains | Overweight | |||
12/05/2024 | -30.09% | Barclays | $75 → $83 | Maintains | Equal-Weight | |||
11/13/2024 | -24.19% | UBS | $72 → $90 | Assumes | Neutral → Neutral | |||
11/07/2024 | -26.72% | Oppenheimer | $86 → $87 | Maintains | Outperform | |||
11/07/2024 | -28.4% | Baird | $80 → $85 | Maintains | Neutral | |||
11/07/2024 | -27.56% | RBC Capital | $81 → $86 | Maintains | Sector Perform | |||
11/07/2024 | -24.19% | Wells Fargo | $84 → $90 | Maintains | Overweight | |||
10/17/2024 | -36.83% | Mizuho | $62 → $75 | Maintains | Neutral | |||
10/07/2024 | -29.25% | Wells Fargo | $80 → $84 | Maintains | Overweight | |||
10/02/2024 | -46.09% | Barclays | $62 → $64 | Maintains | Equal-Weight | |||
10/02/2024 | -27.56% | Oppenheimer | $79 → $86 | Maintains | Outperform | |||
09/27/2024 | -19.98% | B of A Securities | $80 → $95 | Maintains | Buy | |||
09/10/2024 | -32.61% | B of A Securities | $76 → $80 | Upgrade | Neutral → Buy | |||
09/06/2024 | -28.4% | Morgan Stanley | → $85 | Initiates | → Overweight | |||
08/14/2024 | -41.88% | RBC Capital | $61 → $69 | Upgrade | Underperform → Sector Perform | |||
08/02/2024 | -31.77% | Goldman Sachs | $73 → $81 | Maintains | Buy | |||
08/01/2024 | -47.78% | Barclays | $61 → $62 | Maintains | Equal-Weight | |||
08/01/2024 | -48.62% | RBC Capital | $54 → $61 | Maintains | Underperform | |||
08/01/2024 | -32.61% | Wells Fargo | $75 → $80 | Maintains | Overweight | |||
08/01/2024 | -34.3% | Baird | $72 → $78 | Maintains | Neutral | |||
07/15/2024 | -39.35% | Baird | $62 → $72 | Maintains | Neutral | |||
07/10/2024 | -48.62% | Barclays | $62 → $61 | Maintains | Equal-Weight | |||
07/10/2024 | -36.83% | Wells Fargo | $70 → $75 | Maintains | Overweight | |||
07/10/2024 | -38.51% | Goldman Sachs | $66 → $73 | Maintains | Buy | |||
06/27/2024 | -35.98% | Oppenheimer | $70 → $76 | Maintains | Outperform | |||
06/21/2024 | -47.78% | Barclays | $59 → $62 | Maintains | Equal-Weight | |||
05/06/2024 | -42.72% | UBS | $74 → $68 | Downgrade | Buy → Neutral | |||
05/02/2024 | -50.3% | Barclays | $61 → $59 | Maintains | Equal-Weight | |||
05/02/2024 | -41.04% | Oppenheimer | $71 → $70 | Maintains | Outperform | |||
04/18/2024 | -40.2% | Oppenheimer | $66 → $71 | Maintains | Outperform | |||
04/08/2024 | -42.72% | Citigroup | $59 → $68 | Maintains | Neutral | |||
04/02/2024 | -48.62% | Barclays | $59 → $61 | Maintains | Equal-Weight | |||
04/02/2024 | -38.51% | Wells Fargo | $64 → $73 | Maintains | Overweight | |||
02/23/2024 | -47.78% | Mizuho | $62 → $62 | Downgrade | Buy → Neutral | |||
02/20/2024 | — | Argus Research | — | Downgrade | Buy → Hold | |||
01/31/2024 | -49.46% | Deutsche Bank | $65 → $60 | Downgrade | Buy → Hold | |||
01/31/2024 | -59.57% | RBC Capital | $50 → $48 | Maintains | Underperform | |||
01/31/2024 | -49.46% | HSBC | → $60 | Downgrade | Buy → Hold | |||
01/31/2024 | -46.09% | Wells Fargo | $65 → $64 | Maintains | Overweight | |||
01/31/2024 | -50.3% | Barclays | $60 → $59 | Maintains | Equal-Weight | |||
01/30/2024 | — | Melius Research | — | Downgrade | Buy → Hold | |||
01/12/2024 | -57.88% | RBC Capital | $54 → $50 | Downgrade | Sector Perform → Underperform | |||
12/19/2023 | -46.93% | Wells Fargo | $62 → $63 | Maintains | Overweight | |||
12/13/2023 | -54.51% | RBC Capital | $58 → $54 | Maintains | Sector Perform | |||
12/13/2023 | -44.41% | Oppenheimer | → $66 | Reiterates | Outperform → Outperform | |||
12/13/2023 | -49.46% | Barclays | $64 → $60 | Maintains | Equal-Weight | |||
12/13/2023 | -53.67% | Vertical Research | → $55 | Downgrade | Buy → Hold | |||
12/11/2023 | -48.62% | Citigroup | $58 → $61 | Maintains | Neutral | |||
10/23/2023 | -44.41% | Oppenheimer | $78 → $66 | Maintains | Outperform | |||
10/10/2023 | -37.67% | UBS | $80 → $74 | Maintains | Buy | |||
10/09/2023 | -51.15% | Citigroup | $68 → $58 | Maintains | Neutral | |||
09/27/2023 | -41.88% | HSBC | $58 → $69 | Upgrade | Hold → Buy | |||
09/22/2023 | -41.04% | Morgan Stanley | $73 → $70 | Maintains | Overweight | |||
08/03/2023 | -38.51% | Morgan Stanley | $77 → $73 | Maintains | Overweight | |||
08/03/2023 | -43.56% | RBC Capital | $68 → $67 | Maintains | Sector Perform | |||
08/03/2023 | -41.88% | Barclays | $70 → $69 | Maintains | Equal-Weight | |||
08/03/2023 | -34.3% | Oppenheimer | $79 → $78 | Maintains | Outperform | |||
07/12/2023 | -35.14% | Morgan Stanley | $72 → $77 | Maintains | Overweight | |||
07/10/2023 | -37.67% | Wells Fargo | $69 → $74 | Maintains | Overweight | |||
06/01/2023 | -41.04% | Barclays | → $70 | Downgrade | Overweight → Equal-Weight | |||
05/08/2023 | -41.88% | RBC Capital | $68 → $69 | Maintains | Sector Perform |
El último precio objetivo de Johnson Controls Intl (NYSE:JCI) fue comunicado por Goldman Sachs el noviembre 7, 2025. La firma de analistas fijó un precio objetivo para $142.00 que espera JCI a rise dentro de 12 meses (un posible 19.61% upside). 41 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Johnson Controls Intl (NYSE:JCI) fue proporcionada por Goldman Sachs, y Johnson Controls Intl mantuvo su buy calificación.
La última revisión al alza de Johnson Controls International PLC se produjo en mayo 12, 2025, cuando Deutsche Bank elevó su precio objetivo a $112. Deutsche Bank anteriormente tenía a hold para Johnson Controls International PLC.
La última revisión a la baja de Johnson Controls International PLC se produjo en julio 24, 2025, cuando Jefferies cambió su precio objetivo de N/A a $120 para Johnson Controls International PLC.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Johnson Controls Intl, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Johnson Controls Intl se registró el noviembre 7, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 7, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Johnson Controls Intl (JCI) fue un mantuvo con un precio objetivo de $124.00 a $142.00. El precio actual al que cotiza Johnson Controls Intl (JCI) es de $118.72, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.